$17.02
0[0.00%]
At close: Apr 23
$17.02
0[0.00%]
PreMarket: 4:00PM EDT
BioLife Solns
(NASDAQ:BLFS)BioLife Solns Stock (NASDAQ:BLFS), Analyst Ratings, Price Targets, Predictions
BioLife Solutions Inc has a consensus price target of $22.75, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from Jefferies, Craig-Hallum, and TD Cowen on April 4, 2024, August 10, 2023, and August 9, 2023. With an average price target of $23.33 between Jefferies, Craig-Hallum, and TD Cowen, there's an implied 37.09% upside for BioLife Solutions Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
Craig-Hallum
TD Cowen
Lake Street
Stephens & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for BioLife Solns
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/04/2024 | BLFS | Buy Now | BioLife Solns | $17.02 | 29.26% | Jefferies | Matthew Stanton | → $22 | Initiates | → Buy | Get Alert |
| 08/10/2023 | BLFS | Buy Now | BioLife Solns | $17.02 | 35.14% | Craig-Hallum | Matt Hewitt | $29 → $23 | Maintains | Buy | Get Alert |
| 08/09/2023 | BLFS | Buy Now | BioLife Solns | $17.02 | 46.89% | TD Cowen | Max Masucci | $29 → $25 | Maintains | Outperform | Get Alert |
| 08/09/2023 | BLFS | Buy Now | BioLife Solns | $17.02 | 46.89% | Lake Street | Thomas Flaten | $34 → $25 | Maintains | Buy | Get Alert |
| 07/17/2023 | BLFS | Buy Now | BioLife Solns | $17.02 | 70.39% | Stephens & Co. | Jacob Johnson | $27 → $29 | Maintains | Overweight | Get Alert |
| 07/11/2023 | BLFS | Buy Now | BioLife Solns | $17.02 | 70.39% | Craig-Hallum | Matt Hewitt | → $29 | Initiates | → Buy | Get Alert |
| 03/17/2023 | BLFS | Buy Now | BioLife Solns | $17.02 | 58.64% | Stephens & Co. | Jacob Johnson | $31 → $27 | Maintains | Overweight | Get Alert |
| 03/06/2023 | BLFS | Buy Now | BioLife Solns | $17.02 | 64.51% | Oppenheimer | Suraj Kalia | → $28 | Reiterates | → Outperform | Get Alert |
| 05/10/2022 | BLFS | Buy Now | BioLife Solns | $17.02 | 135.02% | Stephens & Co. | Jacob Johnson | $47 → $40 | Maintains | Overweight | Get Alert |
| 05/10/2022 | BLFS | Buy Now | BioLife Solns | $17.02 | 76.26% | Keybanc | Paul Knight | $60 → $30 | Maintains | Overweight | Get Alert |
| 04/25/2022 | BLFS | Buy Now | BioLife Solns | $17.02 | 64.51% | Oppenheimer | Suraj Kalia | → $28 | Upgrade | Perform → Outperform | Get Alert |
| 08/13/2021 | BLFS | Buy Now | BioLife Solutions | $17.02 | 252.53% | Keybanc | Paul Knight | — | Maintains | Overweight | Get Alert |
| 05/14/2021 | BLFS | Buy Now | BioLife Solutions | $17.02 | — | Benchmark | Robert Wasserman | — | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for BioLife Solns (BLFS)?
The latest price target for BioLife Solns (NASDAQ: BLFS) was reported by Jefferies on April 4, 2024. The analyst firm set a price target for $22.00 expecting BLFS to rise to within 12 months (a possible 29.26% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BioLife Solns (BLFS)?
The latest analyst rating for BioLife Solns (NASDAQ: BLFS) was provided by Jefferies, and BioLife Solns initiated their buy rating.
When was the last upgrade for BioLife Solns (BLFS)?
The last upgrade for BioLife Solutions Inc happened on April 25, 2022 when Oppenheimer raised their price target to $28. Oppenheimer previously had a perform for BioLife Solutions Inc.
When was the last downgrade for BioLife Solns (BLFS)?
The last downgrade for BioLife Solutions Inc happened on May 14, 2021 when Benchmark changed their price target from N/A to N/A for BioLife Solutions Inc.
When is the next analyst rating going to be posted or updated for BioLife Solns (BLFS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioLife Solns, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioLife Solns was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.
Is the Analyst Rating BioLife Solns (BLFS) correct?
While ratings are subjective and will change, the latest BioLife Solns (BLFS) rating was a initiated with a price target of $0.00 to $22.00. The current price BioLife Solns (BLFS) is trading at is $17.02, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.